4//SEC Filing
Dreyfus Andrew 4
Accession 0000950170-25-085437
CIK 0001446847other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:26 PM ET
Size
15.8 KB
Accession
0000950170-25-085437
Insider Transaction Report
Form 4
Dreyfus Andrew
Director
Transactions
- Award
Class A Common Stock
2025-06-10+45,000→ 228,313 total
Footnotes (2)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
- [F2]Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001670893
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:26 PM ET
- Size
- 15.8 KB